290 related articles for article (PubMed ID: 25038088)
21. Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research.
Tabor HK; Berkman BE; Hull SC; Bamshad MJ
Am J Med Genet A; 2011 Dec; 155A(12):2916-24. PubMed ID: 22038764
[TBL] [Abstract][Full Text] [Related]
22. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?
Anderson JA; Meyn MS; Shuman C; Zlotnik Shaul R; Mantella LE; Szego MJ; Bowdin S; Monfared N; Hayeems RZ
J Med Ethics; 2017 Aug; 43(8):535-539. PubMed ID: 27888232
[TBL] [Abstract][Full Text] [Related]
23. Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?
Rosenblatt DS
Mol Genet Metab; 2013; 110(1-2):1-2. PubMed ID: 23809103
[No Abstract] [Full Text] [Related]
24. Clinical sequencing: is WGS the better WES?
Meienberg J; Bruggmann R; Oexle K; Matyas G
Hum Genet; 2016 Mar; 135(3):359-62. PubMed ID: 26742503
[TBL] [Abstract][Full Text] [Related]
25. Shared decision making: Implications for return of results from whole-exome and whole-genome sequencing.
Vadaparampil ST; Cragun D
Transl Behav Med; 2018 Jan; 8(1):80-84. PubMed ID: 29385585
[TBL] [Abstract][Full Text] [Related]
26. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
Linthorst GE; Hollak CEM
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
[TBL] [Abstract][Full Text] [Related]
27. Technological advances in DNA sequence enrichment and sequencing for germline genetic diagnosis.
Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
Expert Rev Mol Diagn; 2012 Mar; 12(2):159-73. PubMed ID: 22369376
[TBL] [Abstract][Full Text] [Related]
28. Reducing INDEL calling errors in whole genome and exome sequencing data.
Fang H; Wu Y; Narzisi G; O'Rawe JA; Barrón LT; Rosenbaum J; Ronemus M; Iossifov I; Schatz MC; Lyon GJ
Genome Med; 2014; 6(10):89. PubMed ID: 25426171
[TBL] [Abstract][Full Text] [Related]
29. Scanning the body, sequencing the genome: Dealing with unsolicited findings.
Wouters RHP; Cornelis C; Newson AJ; Bunnik EM; Bredenoord AL
Bioethics; 2017 Nov; 31(9):648-656. PubMed ID: 28975656
[TBL] [Abstract][Full Text] [Related]
30. The Use of Non-Variant Sites to Improve the Clinical Assessment of Whole-Genome Sequence Data.
Ferrarini A; Xumerle L; Griggio F; Garonzi M; Cantaloni C; Centomo C; Vargas SM; Descombes P; Marquis J; Collino S; Franceschi C; Garagnani P; Salisbury BA; Harvey JM; Delledonne M
PLoS One; 2015; 10(7):e0132180. PubMed ID: 26147798
[TBL] [Abstract][Full Text] [Related]
31. Self-guided management of exome and whole-genome sequencing results: changing the results return model.
Yu JH; Jamal SM; Tabor HK; Bamshad MJ
Genet Med; 2013 Sep; 15(9):684-90. PubMed ID: 23619276
[TBL] [Abstract][Full Text] [Related]
32. Managing incidental findings in exome sequencing for research.
Hinchcliffe MJ
Methods Mol Biol; 2014; 1168():207-25. PubMed ID: 24870138
[TBL] [Abstract][Full Text] [Related]
33. Should genetic findings from genome research be reported back to the participants?
Steinsbekk KS; Solberg B
Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2190-3. PubMed ID: 23243670
[TBL] [Abstract][Full Text] [Related]
34. A strategic stakeholder approach for addressing further analysis requests in whole genome sequencing research.
Thornock BS
Life Sci Soc Policy; 2016; 12():4. PubMed ID: 27091475
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a targeted next generation DNA sequencing panel outperforming whole exome sequencing for the identification of clinically relevant genetic variants.
Miller EM; Patterson NE; Zechmeister JM; Bejerano-Sagie M; Delio M; Patel K; Ravi N; Quispe-Tintaya W; Maslov A; Simmons N; Castaldi M; Vijg J; Karabakhtsian RG; Greally JM; Kuo DYS; Montagna C
Oncotarget; 2017 Nov; 8(60):102033-102045. PubMed ID: 29254223
[TBL] [Abstract][Full Text] [Related]
36. To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.
Christenhusz GM; Devriendt K; Dierickx K
Eur J Hum Genet; 2013 Mar; 21(3):248-55. PubMed ID: 22739341
[TBL] [Abstract][Full Text] [Related]
37. Generating a taxonomy for genetic conditions relevant to reproductive planning.
Korngiebel DM; McMullen CK; Amendola LM; Berg JS; Davis JV; Gilmore MJ; Harding CO; Himes P; Jarvik GP; Kauffman TL; Kennedy KA; Simpson DK; Leo MC; Lynch FL; Quigley DI; Reiss JA; Richards CS; Rope AF; Schneider JL; Goddard KA; Wilfond BS
Am J Med Genet A; 2016 Mar; 170(3):565-73. PubMed ID: 26889673
[TBL] [Abstract][Full Text] [Related]
38. Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling.
O'Daniel JM; Lee K
Cancer J; 2012; 18(4):287-92. PubMed ID: 22846728
[TBL] [Abstract][Full Text] [Related]
39. Using the Sankey diagram to visualize article features on the topics of whole-exome sequencing (WES) and whole-genome sequencing (WGS) since 2012: Bibliometric analysis.
Li MJ; Chien TW; Liao KW; Lai FJ
Medicine (Baltimore); 2022 Sep; 101(38):e30682. PubMed ID: 36197161
[TBL] [Abstract][Full Text] [Related]
40. Ethical challenges of the use of whole exome sequencing in the clinic.
Merrill SL; Vaidya A; Pyeritz RE
World J Pediatr Congenit Heart Surg; 2013 Jan; 4(1):58-61. PubMed ID: 23799756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
